| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 747558 | 6-(4-Ethylphenyl)-2-benzenesulfonamidepyridazine-3(2H)-one | 0.0171439890681608 | 0.21074941 |
| NSC 754109 | ethyl 8-(3-methoxybenzyl)-5,8-dihydro-4H-isoxazolo[4,5-g]indole-7-carboxylate | 0.0171439890681608 | 0.18180437 |
| NSC 754240 | 2,9-dimethoxy-6-(2-(piperidin-1-yl)ethoxy)-11H-indeno[1,2-c]quinolin-11-one | 0.0171439890681608 | 0.20306783 |
| NSC 756134 | GSK1023156A | 0.0171439890681608 | 0.23411008 |
| NSC 762149 | N-(4-{2-[(1R,6R,11aS,13S,14aR)-1,13-dihydroxy-4-oxo-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-6-yl]ethyl}phenyl)acetamide | 0.0171439890681608 | -0.14263931 |
| NSC 93287 | Null | 0.0171439890681608 | 0.19752219 |
| NSC 128571 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) | 0.0181211508101519 | 0.20514744 |
| NSC 169774 | Bromocriptine methanesulfonate | 0.0181211508101519 | 0.24946346 |
| NSC 237020 | TA 1067 | 0.0181211508101519 | 0.31221981 |
| NSC 335766 | Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- | 0.0181211508101519 | 0.24466115 |